Wednesday, November 16, 2011

Denver Post: 'Fitzsimons Redevelopment names 4 to board'

Quoting from the breaking news posting by Margaret Jackson:

"The Fitzsimons Redevelopment Authority has named four new board members as part of its plan to refocus the organization charged with overseeing the development of the bioscience park north of the Anschutz Medical Campus in Aurora.

Joining the FRA board are:

Don Elliman Jr., executive director of the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and member of the Children's Hospital board.

William Freytag, former chairman and chief executive of Myogen Inc.

James C.T. Linfield, partner-in-charge of the Colorado office of Cooley LLP.

David Perez, president and chief executive of CaridianBCT, which is becoming TerumoBCT."

Link to

No comments:

Post a Comment